Florida Poison Control Center Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2015
NCT02570971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

mannitol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ciguatera Poisoning (Phase 3)

Poisoning (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1